India's Cadila Healthcare Ltd. (532321.BY) shares surged Monday after it said it has signed a pact with Eli Lilly & Co. (LLY) to discover and develop drugs to treat cardiovascular diseases, which could result in potential milestone payments of up to $300 million.
